Материал: Клинический протокол. ВРТ и искусственная инсеминация

endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome. Reprod Biol Endocrinol [Internet]. 2008;6:37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18764940

85.Xiao Z, Zhou X, Xu W, Yang J, Xie Q. Natural cycle is superior to hormone replacement therapy cycle for vitrificated-preserved frozen-thawed embryo transfer. Syst Biol Reprod

86.Groenewoud ER, Macklon NS, Cohlen BJ, trial study group A. Cryo-thawed embryo transfer: natural versus artificial cycle. A non-inferiority trial. (ANTARCTICA trial). BMC

87.Liao X, Li Z, Dong X, Zhang H. Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer. Int J Clin Exp Pathol

88.Mao G-H, Feng Z, He Y, Huang Y-R. Comparisons of the effects of long-acting and shortacting GnRH agonists on embryo quality, endometrial thickness and pregnancy rate in human in vitro fertilization. Arch Med Sci [Internet]. 2014;10(1):161–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24701229

89.Jung H, Roh HK. The effects of E2 supplementation from the early proliferative phase to the late secretory phase of the endometrium in hMG-stimulated IVF-ET. J Assist Reprod Genet

90.Kol S. Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril [Internet]. 2004;81(1):1–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14711532

91.Корсак ВС, Смирнова АА, Шурыгина ОВ. Регистр центров ВРТ в России. Отчет за 2015г. Проблемы репродукции. 2017;23(5):8–22.

92.Корнеева ЕИ. Федеральные клинические рекомендации. Диагностика и лечение синдрома гиперстимуляции яичников. Москва; 2013.

93.Casper RF. Reducing the Risk of OHSS by GnRH Agonist Triggering. J Clin Endocrinol

94.Leitao VMS, Moroni RM, Seko LMD, Nastri CO, Martins WP. Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials. Fertil Steril [Internet]. 2014;101(3):664–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24360566

95.Sousa M, Cunha M, Teixeira da Silva J, Oliveira C, Silva J, Viana P, et al. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles. Reprod Biol Endocrinol [Internet]. 2015;13:66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26100393

96.Das M, Son W-Y, Buckett W, Tulandi T, Holzer H. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome. Reprod Biomed Online [Internet]. 2014;29(5):545– 51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25262236

97.Refaat B, Dalton E, Ledger WL. Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies. Reprod Biol Endocrinol

150

[Internet]. 2015;13:30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25884617

98.Shaw JL V, Dey SK, Critchley HOD, Horne AW. Current knowledge of the aetiology of human tubal ectopic pregnancy. Hum Reprod Update [Internet]. 16(4):432–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20071358

99.Ankum WM, Mol BW, Van der Veen F, Bossuyt PM. Risk factors for ectopic pregnancy: a meta-analysis. Fertil Steril [Internet]. 1996;65(6):1093–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8641479

100.Audebert A, Pouly JL, Bonifacie B, Yazbeck C. Laparoscopic surgery for distal tubal occlusions: lessons learned from a historical series of 434 cases. Fertil Steril [Internet]. 2014;102(4):1203–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25150389

101.Hjordt Hansen M V, Dalsgaard T, Hartwell D, Skovlund CW, Lidegaard O. Reproductive prognosis in endometriosis. A national cohort study. Acta Obstet Gynecol Scand [Internet]. 2014;93(5):483–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24617701

102.Egbase PE, Al-Sharhan M, Grudzinskas JG. Influence of position and length of uterus on implantation and clinical pregnancy rates in IVF and embryo transfer treatment cycles. Hum

103.Nazari A, Askari HA, Check JH, O’Shaughnessy A. Embryo transfer technique as a cause of ectopic pregnancy in in vitro fertilization. Fertil Steril [Internet]. 1993;60(5):919–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8224280

104.Pandian Z, Marjoribanks J, Ozturk O, Serour G, Bhattacharya S. Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection. Cochrane database Syst Rev. 2013;(7):CD003416.

105.Vloeberghs V, Peeraer K, Pexsters A, D’Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Pract Res Clin Obstet Gynaecol [Internet]. 2009;23(5):691–709. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19632900

106.Özaltın S, Kumbasar S, Savan K. Evaluation of complications developing during and after transvaginal ultrasound - guided oocyte retrieval. Ginekol Pol [Internet]. 2018;89(1):1–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29411339

107.Bodri D, Guillén JJ, Polo A, Trullenque M, Esteve C, Coll O. Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles. Reprod Biomed Online

108.Ludwig AK, Glawatz M, Griesinger G, Diedrich K, Ludwig M. Perioperative and postoperative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals. Hum Reprod [Internet]. 2006;21(12):3235–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877373

109.Sarhan A, Muasher SJ. Surgical complications of in vitro fertilization. Review. Middle East Fert Soc J. 2007;12(1):N1.

110.Serour GI, Aboulghar M, Mansour R, Sattar MA, Amin Y, Aboulghar H. Complications of medically assisted conception in 3,500 cycles. Fertil Steril [Internet]. 1998;70(4):638–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9797090

111.Roest J, Mous H V, Zeilmaker GH, Verhoeff A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update [Internet]. 2(4):345–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9080231

112.Govaerts I, Devreker F, Delbaere A, Revelard P, Englert Y. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. Eur J

151

Obstet Gynecol Reprod Biol [Internet]. 1998;77(2):239–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9578285

113.Кулаков ВИ, Леонов БВ. Экстракорпоральное оплодотворение и его новые направления в лечении женского и мужского бесплодия (теоретические и практические подходы): Руководство для врачей. МИА. Москва; 2004. 782 p.

114.Mashiach S, Bider D, Moran O, Goldenberg M, Ben-Rafael Z. Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertil Steril [Internet]. 1990;53(1):76–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2295348

115.Romanski PA, Melamed A, Elias KM, Stanic AK, Anchan RM. Association between peak estradiol levels and ovarian torsion among symptomatic patients receiving gonadotropin treatment. J Assist Reprod Genet [Internet]. 2017;34(5):627–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28299550

116.Kemmann E, Ghazi DM, Corsan GH. Adnexal torsion in menotropin-induced pregnancies. Obstet Gynecol [Internet]. 1990;76(3 Pt 1):403–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2116611

117.Bouguizane S, Bibi H, Farhat Y, Dhifallah S, Darraji F, Hidar S, et al. [Adnexal torsion: a report of 135 cases]. J Gynecol Obstet Biol Reprod (Paris) [Internet]. 2003;32(6):535–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14593299

118.Chang HC, Bhatt S, Dogra VS. Pearls and pitfalls in diagnosis of ovarian torsion.

119. Huchon C, Fauconnier A. Adnexal torsion: a literature review. Eur J Obstet Gynecol Reprod

120.Mashiach R, Melamed N, Gilad N, Ben-Shitrit G, Meizner I. Sonographic diagnosis of ovarian torsion: accuracy and predictive factors. J Ultrasound Med [Internet]. 2011;30(9):1205–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21876091

121.Steyaert SR, Leroux-Roels GG, Dhont M. Infections in IVF: review and guidelines. Hum

122.Assisted reproductive technology in Europe 2013: results generated from European registers by ESHRE., Calhaz-Jorge C, Christian De Geyter, M S Kupka et al. Revised guidelines for good practice in IVF laboratories (2015). Hum Reprod [Internet]. 2017;32(10):1957–73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26908842

123.Pereira N, Hutchinson AP, Lekovich JP, Hobeika E, Elias RT. Antibiotic Prophylaxis for Gynecologic Procedures prior to and during the Utilization of Assisted Reproductive Technologies: A Systematic Review. J Pathog [Internet]. 2016;2016:4698314. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27047692

124.Arafa M, El Tabie O. Medical treatment of retrograde ejaculation in diabetic patients: a hope for spontaneous pregnancy. J Sex Med [Internet]. 2008;5(1):194–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17433085

125.Ohl DA, Quallich SA, Sønksen J, Brackett NL, Lynne CM. Anejaculation and retrograde ejaculation. Urol Clin North Am [Internet]. 2008;35(2):211--20, viii. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18423241

126.Brackett NL, Ibrahim E, Iremashvili V, Aballa TC, Lynne CM. Treatment for ejaculatory dysfunction in men with spinal cord injury: an 18-year single center experience. J Urol

152

http://www.ncbi.nlm.nih.gov/pubmed/20400139

127.Ohl DA, Quallich SA, Sønksen J, Brackett NL, Lynne CM. Anejaculation: an electrifying approach. Semin Reprod Med [Internet]. 2009;27(2):179–85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19247920

128.Brackett NL, Lynne CM, Ibrahim E, Ohl DA, Sønksen J. Treatment of infertility in men with spinal cord injury. Nat Rev Urol [Internet]. 2010;7(3):162–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20157304

129.Корнеев ИА, Зассеев РД. Преодоление бесплодия у мужчин с ретроградной эякуляцией и анэякуляцией. Урологические ведомости. 2017;7(2):10–5.

130.Colpi GM, Piediferro G, Nerva F, Giacchetta D, Colpi EM, Piatti E. Sperm retrieval for intra-cytoplasmic sperm injection in non-obstructive azoospermia. Minerva Urol Nefrol

131.Deruyver Y, Vanderschueren D, Van der Aa F. Outcome of microdissection TESE compared with conventional TESE in non-obstructive azoospermia: a systematic review. Andrology [Internet]. 2014;2(1):20–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24193894

132.Krausz C, Degl’Innocenti S. Y chromosome and male infertility: update, 2006. Front Biosci

133.Ghanem M, Bakr NI, Elgayaar MA, El Mongy S, Fathy H, Ibrahim A-HA. Comparison of the outcome of intracytoplasmic sperm injection in obstructive and non-obstructive azoospermia in the first cycle: a report of case series and meta-analysis. Int J Androl

[Internet]. 2005;28(1):16–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15679616

134. Vernaeve V, Tournaye H, Osmanagaoglu K, Verheyen G, Van Steirteghem A, Devroey P. Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermia. Fertil Steril

135.Vloeberghs V, Verheyen G, Haentjens P, Goossens A, Polyzos NP, Tournaye H. How successful is TESE-ICSI in couples with non-obstructive azoospermia? Hum Reprod

136.Aksglaede L, Juul A. Testicular function and fertility in men with Klinefelter syndrome: a review. Eur J Endocrinol [Internet]. 2013;168(4):R67--76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23504510

137.Gies I, De Schepper J, Goossens E, Van Saen D, Pennings G, Tournaye H. Spermatogonial stem cell preservation in boys with Klinefelter syndrome: to bank or not to bank, that’s the

question. Fertil Steril [Internet]. 2012;98(2):284–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22608314

138.Kastrop PM, Weima SM, Van Kooij RJ, Te Velde ER. Comparison between intracytoplasmic sperm injection and in-vitro fertilization (IVF) with high insemination concentration after total fertilization failure in a previous IVF attempt. Hum Reprod

139.Verheyen G, Tournaye H, Staessen C, De Vos A, Vandervorst M, Van Steirteghem A. Controlled comparison of conventional in-vitro fertilization and intracytoplasmic sperm

153

injection in patients with asthenozoospermia. Hum Reprod [Internet]. 1999;14(9):2313–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10469701

140.Payne D, Flaherty SP, Jeffrey R, Warnes GM, Matthews CD. Successful treatment of severe male factor infertility in 100 consecutive cycles using intracytoplasmic sperm injection. Hum

141.Plachot M, Belaisch-Allart J, Mayenga J-M, Chouraqui A, Tesquier L, Serkine AM. Outcome of conventional IVF and ICSI on sibling oocytes in mild male factor infertility.

142.Henkel RR, Schill W-B. Sperm preparation for ART. Reprod Biol Endocrinol [Internet]. 2003;1:108. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14617368

143.Beydola T, Sharma RK, Agarwal A. Sperm preparation and selection techniques. Med Surg Manag male Infertil. 2014;(29):244–51.

144.on Good EGG. Revised guidelines for good practice in IVF laboratories (2015): Guideline of the European Society of Human Reproduction and Embryology.

145.Huang Z, Li J, Wang L, Yan J, Shi Y, Li S. Brief co-incubation of sperm and oocytes for in vitro fertilization techniques. Cochrane database Syst Rev. 2013;(4):CD009391.

146.Kazem R, Thompson LA, Srikantharajah A, Laing MA, Hamilton MP, Templeton A. Cryopreservation of human oocytes and fertilization by two techniques: in-vitro fertilization and intracytoplasmic sperm injection. Hum Reprod [Internet]. 1995;10(10):2650–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8567786

147.Gook DA, Edgar DH. Human oocyte cryopreservation. Hum Reprod Update [Internet]. 13(6):591–605. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17846105

148.Harton GL, Magli MC, Lundin K, Montag M, Lemmen J, Harper JC, et al. ESHRE PGD

Consortium/Embryology Special Interest Group--best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod [Internet]. 2011;26(1):41–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20966459

149.Thornhill AR, DeDie-Smulders CE, Geraedts JP, Harper JC, Harton GL, Lavery SA, et al.

ESHRE PGD Consortium “Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)”. Hum Reprod [Internet].

2005;20(1):35–48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15539444

150.ESHRE Capri Workshop Group. Intracytoplasmic sperm injection (ICSI) in 2006: evidence and evolution. Hum Reprod Update [Internet]. 13(6):515–26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17630396

151.Practice Committees of the American Society for Reproductive Medicine and Society for Assisted Reproductive Technology. Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion. Fertil Steril [Internet]. 2012;98(6):1395–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22981171

152.van der Westerlaken L, Helmerhorst F, Dieben S, Naaktgeboren N. Intracytoplasmic sperm injection as a treatment for unexplained total fertilization failure or low fertilization after conventional in vitro fertilization. Fertil Steril [Internet]. 2005;83(3):612–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15749489

153.Kinzer DR, Barrett CB, Powers RD. Prognosis for clinical pregnancy and delivery after total fertilization failure during conventional in vitro fertilization or intracytoplasmic sperm

154